Replies to post #1182 on Repros Therapeutics, Inc. (RPRX)

[io_io]

One more:

<<<<<"
The keys for shaping the Proellex market (again just off hand)
1) Highlighting the MOA of the drug and build on the abundant data that shows this class of drugs works
2) Identifying the urgent need for new therapies for endometriosis and uterine fibroids
3) Promoting the safety and efficacy of the drug in the core proposed indications
4) Communicating potential uses beyond the core proposed indications">>>>


5) Differentiating it from Asoprisnil.